0 Комментарии
0 Поделились
252 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Маркет
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Beyond Hormones: The Expanding Role of Anti-Infectives and Therapeutics in the Gynecology Drug MarketThe global gynecology drug market is witnessing significant growth beyond traditional hormonal therapies, with a notable expansion in the use of anti-infectives, analgesics, and topical treatments for a wide range of conditions. The Anti-Infectives and Therapeutics in the Gynecology Drug Market represents a critical and rapidly evolving segment, driven by the high prevalence of...0 Комментарии 0 Поделились 220 Просмотры 0 предпросмотр
-
The Shift to Homecare: End-User Evolution in the Non-Steroidal Anti-Inflammatory Drug MarketThe Shift to Homecare: End-User Evolution in the Non-Steroidal Anti-Inflammatory Drug Market Summary: The NSAID market is seeing a significant shift from hospitals to homecare, driven by patient preference for at-home chronic condition management. Article: The Non-Steroidal Anti-Inflammatory Drug Market is a dynamic ecosystem where the points of care are as important as the...0 Комментарии 0 Поделились 128 Просмотры 0 предпросмотр
-
Global Cefalexin API Market to Reach USD 871 Million by 2034According to a new report from Intel Market Research, the global Cefalexin API market was valued at USD 571 million in 2024 and is projected to reach USD 871 million by 2034, growing at a robust CAGR of 6.4% during the forecast period (2025–2034). This growth is propelled by the increasing prevalence of bacterial infections, rising demand for generic antibiotics, and expanding...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Global Pharmaceutical Traceability Code Scanning Market Growing at 7.9% CAGRAccording to a new report from Intel Market Research, the global Pharmaceutical Traceability Code Scanning All-in-One Machine market was valued at USD 259 million in 2025 and is projected to reach USD 441 million by 2034, growing at a robust CAGR of 7.9% during the forecast period (2026–2034). This growth is propelled by stringent pharmaceutical serialization mandates globally, rising...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр